Nihon Kohden (OTCMKTS:NHNKY) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS

by · The Cerbat Gem

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.06), Zacks reports. Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%.

Nihon Kohden Stock Performance

NHNKY stock opened at $9.40 on Wednesday. The company has a 50-day simple moving average of $10.07 and a 200 day simple moving average of $9.77. The company has a market capitalization of $1.58 billion, a P/E ratio of 17.09 and a beta of 0.42. The company has a quick ratio of 2.64, a current ratio of 3.98 and a debt-to-equity ratio of 0.12. Nihon Kohden has a fifty-two week low of $8.12 and a fifty-two week high of $13.61.

Analyst Ratings Changes

Separately, UBS Group lowered Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 12th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock has a consensus rating of “Hold”.

View Our Latest Stock Report on Nihon Kohden

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and sells electronic medical equipment and related services. Founded in 1951, the company is headquartered in Tokyo, Japan. Its products include patient monitors, electrocardiographs, defibrillators and other equipment used in emergency and critical care. Nihon Kohden also makes diagnostic systems for areas such as neurology and hematology, along with medical information systems and services that support clinical workflows.

Further Reading